Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-05-15 09:33 am Purchase | 2025-03-31 | 13G | ALIGOS THERAPEUTICS INC NE ALGS | Woodline Partners LP | 315,383 5.200% | 315,383 (New Position) | Filing History |
| 2025-05-15 09:32 am Purchase | 2025-03-31 | 13G | TENAYA THERAPEUTICS INC TNYA | Woodline Partners LP | 5,916,167 6.800% | 5,916,167 (New Position) | Filing History |
| 2025-05-15 09:30 am Purchase | 2025-03-31 | 13G | OUTSET MED INC OM | Woodline Partners LP | 1,325,784 7.500% | 1,325,784 (New Position) | Filing History |
| 2025-02-14 4:06 pm Sale | 2024-12-31 | 13G | TRAVERE THERAPEUTICS INC TVTX | Woodline Partners LP | 2,114,056 2.400% | -2,226,284 (-51.29%) | Filing History |
| 2025-02-14 4:06 pm Sale | 2024-12-31 | 13G | PROTARA THERAPEUTICS INC TARA | Woodline Partners LP | 1,331,258 3.900% | -245,309 (-15.56%) | Filing History |
| 2025-02-14 4:05 pm Sale | 2024-12-31 | 13G | GUARDIAN PHARMACY SVCS INC CL GRDN | Woodline Partners LP | 415,120 4.500% | -153,011 (-26.93%) | Filing History |
| 2024-11-14 1:01 pm Purchase | 2024-09-30 | 13G | GUARDIAN PHARMACY SVCS INC CL GRDN | Woodline Partners LP | 568,131 6.200% | 568,131 (New Position) | Filing History |
| 2024-11-14 1:01 pm Purchase | 2024-09-30 | 13G | TRAVERE THERAPEUTICS INC TVTX | Woodline Partners LP | 4,340,340 5.700% | 4,340,340 (New Position) | Filing History |
| 2024-11-14 1:00 pm Purchase | 2024-09-30 | 13G | PROTARA THERAPEUTICS INC TARA | Woodline Partners LP | 1,576,567 7.400% | 1,576,567 (New Position) | Filing History |
| 2024-11-14 1:00 pm Purchase | 2024-09-30 | 13G | ZEVRA THERAPEUTICS INC ZVRA | Woodline Partners LP | 4,048,653 7.700% | 4,048,653 (New Position) | Filing History |
| 2024-02-12 4:38 pm Purchase | 2023-12-31 | 13G | VERA THERAPEUTICS INC VERA | Woodline Partners LP | 1,140,632 2.200% | 1,140,632 (New Position) | Filing History |
| 2024-02-12 4:33 pm Sale | 2023-12-31 | 13G | CALIDI BIOTHERAPEUTICS, INC. C CLDI | Woodline Partners LP | 1,042 0.400% | -2,291 (-68.74%) | Filing History |
| 2024-02-12 4:32 pm Sale | 2023-12-31 | 13G | OPY ACQUISITION CORP I COM CL OHAA | Woodline Partners LP | 0 0.000% | -200,000 (Position Closed) | Filing History |
| 2023-02-10 4:10 pm Sale | 2022-12-31 | 13G | ASCENDANT DIGITAL ACQUISTION C ACDI | Woodline Partners LP | 1,286,000 4.300% | -626,500 (-32.76%) | Filing History |
| 2023-02-10 4:10 pm Purchase | 2022-12-31 | 13G | OPY ACQUISITION CORP I COM CL OHAA | Woodline Partners LP | 200,000 8.100% | 200,000 (New Position) | Filing History |
| 2023-02-10 4:09 pm Sale | 2022-12-31 | 13G | SENTI BIOSCIENCES INC SNTI | Woodline Partners LP | 0 0.000% | -200,000 (Position Closed) | Filing History |
| 2023-02-10 4:08 pm Sale | 2022-12-31 | 13G | CALIDI BIOTHERAPEUTICS, INC. C CLDI | Woodline Partners LP | 3,333 9.700% | -13,167 (-79.80%) | Filing History |
| 2022-02-11 07:26 am Purchase | 2021-12-31 | 13G | DYNAMIC SPL PURP CORP DYNS | Woodline Partners LP | 2,000,000 8.400% | 2,000,000 (New Position) | Filing History |
| 2022-02-11 07:25 am Purchase | 2021-12-31 | 13G | ASCENDANT DIGITAL ACQUISTION C ACDI | Woodline Partners LP | 1,912,500 6.400% | 1,912,500 (New Position) | Filing History |
| 2022-02-11 07:23 am Purchase | 2021-12-31 | 13G | CALIDI BIOTHERAPEUTICS, INC. C CLDI | Woodline Partners LP | 16,500 8.600% | 16,500 (New Position) | Filing History |